These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22989054)

  • 1. ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder.
    Milanesi E; Minelli A; Cattane N; Cattaneo A; Mora C; Barbon A; Mallei A; Popoli M; Florio V; Conca A; Bignotti S; Gennarelli M
    BMC Psychiatry; 2012 Sep; 12():145. PubMed ID: 22989054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered mRNA expressions for N-methyl-D-aspartate receptor-related genes in WBC of patients with major depressive disorder.
    Lin CH; Huang MW; Lin CH; Huang CH; Lane HY
    J Affect Disord; 2019 Feb; 245():1119-1125. PubMed ID: 30699855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alteration of hypoxia inducible factor-1 (HIF-1) and its target genes in mood disorder patients.
    Shibata T; Yamagata H; Uchida S; Otsuki K; Hobara T; Higuchi F; Abe N; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():222-9. PubMed ID: 23333658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder.
    Hung YY; Lin CC; Kang HY; Huang TL
    Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of circulating blood microRNA-374 and microRNA-10 levels in the pathogenesis and therapeutic mechanisms of major depressive disorder.
    Liu W; Zhang F; Zheng Y; He S; Zhang T; Guo Q; Xu H; Chen H; Liu C; Yu S; Jiang K; Li H; Li G; Wang X; Liu X
    Neurosci Lett; 2021 Oct; 763():136184. PubMed ID: 34418506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. tiRNA-Gly-GCC-001 in major depressive disorder: Promising diagnostic and therapeutic biomarker.
    Tian H; Gao S; Xu M; Yang M; Shen M; Liu J; Li G; Zhuang D; Hu Z; Wang C
    Br J Pharmacol; 2024 Jul; 181(13):1952-1972. PubMed ID: 38439581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological tests for major depressive disorder that involve leukocyte gene expression assays.
    Watanabe SY; Iga J; Ishii K; Numata S; Shimodera S; Fujita H; Ohmori T
    J Psychiatr Res; 2015; 66-67():1-6. PubMed ID: 25943949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression: correlations with severity and duration of illness.
    Amidfar M; Kim YK; Colic L; Arbabi M; Mobaraki G; Hassanzadeh G; Walter M
    Nord J Psychiatry; 2017 May; 71(4):282-288. PubMed ID: 28125323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment.
    Mellon SH; Wolkowitz OM; Schonemann MD; Epel ES; Rosser R; Burke HB; Mahan L; Reus VI; Stamatiou D; Liew CC; Cole SW
    Transl Psychiatry; 2016 May; 6(5):e821. PubMed ID: 27219347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative splicing of SMPD1 coding for acid sphingomyelinase in major depression.
    Rhein C; Reichel M; Kramer M; Rotter A; Lenz B; Mühle C; Gulbins E; Kornhuber J
    J Affect Disord; 2017 Feb; 209():10-15. PubMed ID: 27866044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hsa_circRNA_103636: potential novel diagnostic and therapeutic biomarker in Major depressive disorder.
    Cui X; Niu W; Kong L; He M; Jiang K; Chen S; Zhong A; Li W; Lu J; Zhang L
    Biomark Med; 2016 Sep; 10(9):943-52. PubMed ID: 27404501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of microRNAs in major depressive disorder and its implication on diagnosis and therapeutic response.
    Zhou L; Zhu Y; Chen W; Tang Y
    J Affect Disord; 2021 May; 286():80-86. PubMed ID: 33714174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant Expression of Intracellular let-7e, miR-146a, and miR-155 Correlates with Severity of Depression in Patients with Major Depressive Disorder and Is Ameliorated after Antidepressant Treatment.
    Hung YY; Wu MK; Tsai MC; Huang YL; Kang HY
    Cells; 2019 Jun; 8(7):. PubMed ID: 31252530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects.
    Goswami DB; Jernigan CS; Chandran A; Iyo AH; May WL; Austin MC; Stockmeier CA; Karolewicz B
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():126-33. PubMed ID: 23261523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder.
    Tadić A; Wagner S; Gorbulev S; Dahmen N; Hiemke C; Braus DF; Lieb K
    BMC Psychiatry; 2011 Jan; 11():16. PubMed ID: 21269443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment.
    Cattaneo A; Sesta A; Calabrese F; Nielsen G; Riva MA; Gennarelli M
    Neuropsychopharmacology; 2010 Jun; 35(7):1423-8. PubMed ID: 20164831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression biomarkers of response to citalopram treatment in major depressive disorder.
    Mamdani F; Berlim MT; Beaulieu MM; Labbe A; Merette C; Turecki G
    Transl Psychiatry; 2011 Jun; 1(6):e13. PubMed ID: 22832429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of microRNA-124 expression in peripheral blood mononuclear cells in pre- and post-treatment patients with major depressive disorder.
    He S; Liu X; Jiang K; Peng D; Hong W; Fang Y; Qian Y; Yu S; Li H
    J Psychiatr Res; 2016 Jul; 78():65-71. PubMed ID: 27078210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte telomere length is reduced in patients with major depressive disorder.
    Pisanu C; Tsermpini EE; Skokou M; Kordou Z; Gourzis P; Assimakopoulos K; Congiu D; Meloni A; Balasopoulos D; Patrinos GP; Squassina A
    Drug Dev Res; 2020 May; 81(3):268-273. PubMed ID: 31675136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized medicine in major depressive disorder -- opportunities and pitfalls.
    Miller DB; O'Callaghan JP
    Metabolism; 2013 Jan; 62 Suppl 1(0 1):S34-9. PubMed ID: 23021040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.